Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes

Characterization of the head-twitch response induced by hallucinogens in mice

(2013) Adam L. Halberstadt et al.   PSYCHOPHARMACOLOGY

A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

(2012) Peter Oehen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades

(2012) Hannah K. Delille et al.   NEUROPHARMACOLOGY

Designer drugs: a medicinal chemistry perspective

(2011) F. Ivy Carroll et al.   Annals of the New York Academy of Sciences

Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs

(2011) Miguel Fribourg et al.   CELL

Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers

(2011) Matthew W. Johnson et al.   DRUG AND ALCOHOL DEPENDENCE

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

(2011) Katherine A MacLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists

(2011) José L. Moreno et al.   NEUROSCIENCE LETTERS

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

Serotonin, But Not N-Methyltryptamines, Activates the Serotonin 2A Receptor Via a  -Arrestin2/Src/Akt Signaling Complex In Vivo

(2010) C. L. Schmid et al.   JOURNAL OF NEUROSCIENCE

Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents

(2010) D. Matthew Walentiny et al.   PSYCHOPHARMACOLOGY

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter

(2009) Nicholas V. Cozzi et al.   JOURNAL OF NEURAL TRANSMISSION

The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator

(2009) D. Fontanilla et al.   SCIENCE

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Identification of a serotonin/glutamate receptor complex implicated in psychosis

(2008) Javier González-Maeso et al.   NATURE

Agonist-directed signaling of the serotonin 2A receptor depends on  -arrestin-2 interactions in vivo

(2008) C. L. Schmid et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI

(2008) Danuta Marona-Lewicka et al.   PSYCHOPHARMACOLOGY

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors

(2008) Adam L. Halberstadt et al.   PSYCHOPHARMACOLOGY

Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward

(2007) Daniela Braida et al.   BIOLOGICAL PSYCHIATRY